Moderna is an American biotechnology company founded in 2010 and based in Cambridge, Massachusetts. It focuses on developing messenger RNA (mRNA) therapeutics and vaccines for infectious diseases, cancer, and rare disorders. The company gained global prominence for its COVID-19 vaccine, which was among the first mRNA-based vaccines authorized for emergency use. Moderna continues to expand its pipeline with treatments targeting a range of health conditions.